We are live on ! Find out more
MIRO

Miromatrix Medical Inc. Common Stock
MIRO

Delisted

MIRO was delisted on the 12th of December, 2023.

Back to rankings

32 hedge funds and large institutions have $11.6M invested in Miromatrix Medical Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

3% more funds holding

Funds holding: 31 → 32 (+1)

5% more capital invested

Capital invested by funds: $11.1M → $11.6M (+$522K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
11
Reduced
4
Closed
–
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$63.6K
2
BlackRock
BlackRock
New York
+$24.2K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$17.6K
4
HWM
HighMark Wealth Management
Minnesota
+$13.2K
5
Northern Trust
Northern Trust
Illinois
+$11.2K

Top Sellers

Rank Fund Capital Flow
1
GIPM
G2 Investment Partners Management
New York
-$76.6K
2
PCM
Perkins Capital Management
Minnesota
-$42.2K
3
FLAM
First Light Asset Management
Minnesota
-$11.8K
4
UBS Group
UBS Group
Switzerland
-$6.52K
Name Holding Trade Value Shares
Change 		Change in
Stake
FLAM
1
First Light Asset Management
Minnesota
$3.9M -$11.8K -8,916 -0.4%
GS
2
Gagnon Securities
New York
$2.52M +$6.21K +4,712 +0.3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.14M – – –
GA
4
Gagnon Advisors
New York
$974K – – –
RI
5
RTW Investments
New York
$779K – – –
MC
6
Mayo Clinic
Minnesota
$336K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$329K +$63.6K +48,195 +35%
GIPM
8
G2 Investment Partners Management
New York
$316K -$76.6K -58,088 -24%
SFP
9
Sweet Financial Partners
Minnesota
$241K +$3.23K +2,453 +2%
PCM
10
Perkins Capital Management
Minnesota
$209K -$42.2K -32,000 -21%
RJA
11
Raymond James & Associates
Florida
$113K – – –
MFG
12
Merit Financial Group
Georgia
$107K – – –
BlackRock
13
BlackRock
New York
$102K +$24.2K +18,372 +46%
HWM
14
HighMark Wealth Management
Minnesota
$91K +$13.2K +10,000 +24%
LWAM
15
Legacy Wealth Asset Management
Minnesota
$90.5K +$1.53K +1,164 +2%
Envestnet Asset Management
16
Envestnet Asset Management
Illinois
$84.1K – – –
State Street
17
State Street
Massachusetts
$52.5K – – –
Commonwealth Equity Services
18
Commonwealth Equity Services
Massachusetts
$47K – – –
Northern Trust
19
Northern Trust
Illinois
$41.5K +$11.2K +8,530 +56%
TWM
20
Tradition Wealth Management
Minnesota
$39K +$1.45K +1,100 +5%
WVP
21
Worth Venture Partners
New Jersey
$38.1K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$27K +$17.6K +13,321 +666%
Charles Schwab
23
Charles Schwab
California
$19.3K – – –
US Bancorp
24
US Bancorp
Minnesota
$17.5K – – –
HWA
25
HHM Wealth Advisors
Tennessee
$6.13K – – –
1
2

MIRO Hedge Fund Activity: Q2 2023 in Review

32 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q2 2023, worth a combined $11.6M — up 4.7% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MIRO positions and 0 closed out — a net gain of 1 holder — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $63.6K. The largest seller was G2 Investment Partners Management, cutting an estimated $76.6K.

  • 32 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q2 2023, up from 31 in Q1 2023.
  • Funds reported $11.6M of Miromatrix Medical Inc. Common Stock stock for Q2 2023, up 4.7% quarter-over-quarter.
  • 1 fund opened new Miromatrix Medical Inc. Common Stock positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest Miromatrix Medical Inc. Common Stock buyer in Q2 2023 was Geode Capital Management, an estimated $63.6K added.
  • The largest Miromatrix Medical Inc. Common Stock seller in Q2 2023 was G2 Investment Partners Management, an estimated $76.6K sold.

Based on aggregated 13F filings for Q2 2023.